1004 related articles for article (PubMed ID: 18089564)
1. Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin.
Robling AG; Niziolek PJ; Baldridge LA; Condon KW; Allen MR; Alam I; Mantila SM; Gluhak-Heinrich J; Bellido TM; Harris SE; Turner CH
J Biol Chem; 2008 Feb; 283(9):5866-75. PubMed ID: 18089564
[TBL] [Abstract][Full Text] [Related]
2. Sost downregulation and local Wnt signaling are required for the osteogenic response to mechanical loading.
Tu X; Rhee Y; Condon KW; Bivi N; Allen MR; Dwyer D; Stolina M; Turner CH; Robling AG; Plotkin LI; Bellido T
Bone; 2012 Jan; 50(1):209-17. PubMed ID: 22075208
[TBL] [Abstract][Full Text] [Related]
3. Modulation of sclerostin expression by mechanical loading and bone morphogenetic proteins in osteogenic cells.
Papanicolaou SE; Phipps RJ; Fyhrie DP; Genetos DC
Biorheology; 2009; 46(5):389-99. PubMed ID: 19940355
[TBL] [Abstract][Full Text] [Related]
4. The Wnt Inhibitor Sclerostin Is Up-regulated by Mechanical Unloading in Osteocytes in Vitro.
Spatz JM; Wein MN; Gooi JH; Qu Y; Garr JL; Liu S; Barry KJ; Uda Y; Lai F; Dedic C; Balcells-Camps M; Kronenberg HM; Babij P; Pajevic PD
J Biol Chem; 2015 Jul; 290(27):16744-58. PubMed ID: 25953900
[TBL] [Abstract][Full Text] [Related]
5. Mechanical loading-related changes in osteocyte sclerostin expression in mice are more closely associated with the subsequent osteogenic response than the peak strains engendered.
Moustafa A; Sugiyama T; Prasad J; Zaman G; Gross TS; Lanyon LE; Price JS
Osteoporos Int; 2012 Apr; 23(4):1225-34. PubMed ID: 21573880
[TBL] [Abstract][Full Text] [Related]
6. Bone density ligand, Sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity.
Ellies DL; Viviano B; McCarthy J; Rey JP; Itasaki N; Saunders S; Krumlauf R
J Bone Miner Res; 2006 Nov; 21(11):1738-49. PubMed ID: 17002572
[TBL] [Abstract][Full Text] [Related]
7. Paradoxical response to mechanical unloading in bone loss, microarchitecture, and bone turnover markers.
Sun X; Yang K; Wang C; Cao S; Merritt M; Hu Y; Xu X
Int J Med Sci; 2015; 12(3):270-9. PubMed ID: 25798053
[TBL] [Abstract][Full Text] [Related]
8. Mechanical load increases in bone formation via a sclerostin-independent pathway.
Morse A; McDonald MM; Kelly NH; Melville KM; Schindeler A; Kramer I; Kneissel M; van der Meulen MC; Little DG
J Bone Miner Res; 2014 Nov; 29(11):2456-67. PubMed ID: 24821585
[TBL] [Abstract][Full Text] [Related]
9. PTH receptor signaling in osteocytes governs periosteal bone formation and intracortical remodeling.
Rhee Y; Allen MR; Condon K; Lezcano V; Ronda AC; Galli C; Olivos N; Passeri G; O'Brien CA; Bivi N; Plotkin LI; Bellido T
J Bone Miner Res; 2011 May; 26(5):1035-46. PubMed ID: 21140374
[TBL] [Abstract][Full Text] [Related]
10. Sclerostin: From Molecule to Clinical Biomarker.
Omran A; Atanasova D; Landgren F; Magnusson P
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563144
[TBL] [Abstract][Full Text] [Related]
11. Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling.
Li X; Zhang Y; Kang H; Liu W; Liu P; Zhang J; Harris SE; Wu D
J Biol Chem; 2005 May; 280(20):19883-7. PubMed ID: 15778503
[TBL] [Abstract][Full Text] [Related]
12. Sclerostin, an osteocytes-derived bone-forming inhibitor.
Włodarski KH; Galus R; Brodzikowska A; Włodarski PK
Pol Orthop Traumatol; 2013 Jul; 78():151-4. PubMed ID: 23820854
[TBL] [Abstract][Full Text] [Related]
13. Lrp4, a novel receptor for Dickkopf 1 and sclerostin, is expressed by osteoblasts and regulates bone growth and turnover in vivo.
Choi HY; Dieckmann M; Herz J; Niemeier A
PLoS One; 2009 Nov; 4(11):e7930. PubMed ID: 19936252
[TBL] [Abstract][Full Text] [Related]
14. Osteocytes and WNT: the mechanical control of bone formation.
Galli C; Passeri G; Macaluso GM
J Dent Res; 2010 Apr; 89(4):331-43. PubMed ID: 20200416
[TBL] [Abstract][Full Text] [Related]
15. Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/beta-catenin signaling.
Lin C; Jiang X; Dai Z; Guo X; Weng T; Wang J; Li Y; Feng G; Gao X; He L
J Bone Miner Res; 2009 Oct; 24(10):1651-61. PubMed ID: 19419300
[TBL] [Abstract][Full Text] [Related]
16. Mechanical stimulation in vivo reduces osteocyte expression of sclerostin.
Robling AG; Bellido T; Turner CH
J Musculoskelet Neuronal Interact; 2006; 6(4):354. PubMed ID: 17185821
[No Abstract] [Full Text] [Related]
17. The matricellular protein periostin is required for sost inhibition and the anabolic response to mechanical loading and physical activity.
Bonnet N; Standley KN; Bianchi EN; Stadelmann V; Foti M; Conway SJ; Ferrari SL
J Biol Chem; 2009 Dec; 284(51):35939-50. PubMed ID: 19837663
[TBL] [Abstract][Full Text] [Related]
18. Differential responses of mechanosensitive osteocyte proteins in fore- and hindlimbs of hindlimb-unloaded rats.
Metzger CE; Brezicha JE; Elizondo JP; Narayanan SA; Hogan HA; Bloomfield SA
Bone; 2017 Dec; 105():26-34. PubMed ID: 28782619
[TBL] [Abstract][Full Text] [Related]
19. Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST/sclerostin in osteocytes.
Kim JY; Lee SK; Jo KJ; Song DY; Lim DM; Park KY; Bonewald LF; Kim BJ
Life Sci; 2013 Mar; 92(10):533-40. PubMed ID: 23357248
[TBL] [Abstract][Full Text] [Related]
20. Osteocyte-derived sclerostin inhibits bone formation: its role in bone morphogenetic protein and Wnt signaling.
ten Dijke P; Krause C; de Gorter DJ; Löwik CW; van Bezooijen RL
J Bone Joint Surg Am; 2008 Feb; 90 Suppl 1():31-5. PubMed ID: 18292354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
